Actualización de la terapia cetogénica para epilepsia farmacorresistente y otras enfermedades neurometabólicas
Med. infant; 29 (3), 2022
Results: 4
Dieta Cetogénica en el paciente con epilepsia refractaria
Rev. chil. pediatr; 91 (5), 2020
INTRODUCCIÓN: La epilepsia afecta a 0,5% a 1% de la población, iniciándose en la infancia en el 60% de los casos. El 25% de los niños que la presentan, tienen epilepsia refractaria (ER) a fármacos antiepilépticos (FAE) y en ellos la dieta cetogénica (DC) surge como un tratamiento no farmacológic...
The use of a formula-based ketogenic diet in children with refractory epilepsy
Arq. neuropsiquiatr; 75 (4), 2017
ABSTRACT The ketogenic diet (KD) is a nonpharmacologic treatment that has been used for refractory epilepsy since 1921. The KD is a high-fat, low-carbohydrate, and restricted protein diet, which is calculated and weighed for each individual patient. Introducing and maintaining the diet for a long time re...
Ketogenic diet for epilepsy treatment
Arq. neuropsiquiatr; 74 (10), 2016
ABSTRACT The ketogenic diet (KD), a high-fat, low-carbohydrate, and adequate-protein diet is an established, effective nonpharmacologic treatment option for intractable childhood epilepsy. The KD was developed in 1921 and even though it has been increasingly used worldwide in the past decade, many neurol...